A phase II study of induction PD-1 blockade in subjects with locally advanced mismatch repair-deficient rectal adenocarcinoma.

被引：0
|
作者：
Cercek, Andrea
Stadler, Zsofia Kinga
Cohen, Jenna L.
Weiss, Jill A.
Lamendola-Essel, Michelle F.
Krishnan, Asha
Yaeger, Rona
Segal, Neil Howard
Connell, Louise Catherine
El Dika, Imane H.
Kemeny, Nancy E.
Saltz, Leonard B.
Smith, Jesse Joshua
Nash, Garrett Michael
Paty, Philip
Garcia-Aguilar, Julio
Weiser, Martin R.
Diaz, Luis A.
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Thorac Oncol Serv, 1275 York Ave, New York, NY 10021 USA
[3] Weill Cornell Med Coll, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Colorectal Oncol, 1275 York Ave, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Surg, Colorectal Serv, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4123
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (P1CC): a single-centre, parallel-group, noncomparative, randomised, phase 2 trial
    Hu, Huabin
    Kang, Liang
    Zhang, Jianwei
    Wu, Zehua
    Wang, Hui
    Huang, Meijin
    Lan, Ping
    Wu, Xiaojian
    Wang, Chao
    Cao, Wuteng
    Hu, Jiancong
    Huang, Yan
    Huang, Liang
    Wang, Huaiming
    Shi, Lishuo
    Cai, Yue
    Shen, Cailu
    Ling, Jiayu
    Xie, Xiaoyu
    Cai, Yonghua
    He, Xiaowen
    Dou, Ruoxu
    Zhou, Jiaming
    Ma, Tenghui
    Zhang, Xingwei
    Luo, Shuangling
    Deng, Weihao
    Ling, Li
    Liu, Hao
    Deng, Yanhong
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (01): : 38 - 48
  • [32] Neoadjuvant Arterial Embolization Chemotherapy Combined PD-1 Inhibitor for Locally Advanced Rectal Cancer (NECI Study): a protocol for a phase II study
    Fan, Yiqun
    Zhu, Xiaoling
    Xu, Chengcai
    Ding, Caiyou
    Hu, Jibo
    Hong, Qiang
    Wang, Jianwei
    BMJ OPEN, 2023, 13 (03):
  • [33] PD-1 blockade in deficient mismatch repair mixed adenoneuroendocrine carcinoma of the stomach: new hope for an orphan disease
    Ricco, Beatrice
    Salati, Massimiliano
    Reggiani Bonetti, Luca
    Dominici, Massimo
    Luppi, Gabriele
    TUMORI JOURNAL, 2020, 106 (06): : NP57 - NP62
  • [34] Clinical and molecular features of responders to PD-1 blockade for patients with microsatellite instability high or mismatch repair deficient advanced gastrointestinal tumors.
    Chida, Keigo
    Kawazoe, Akihito
    Kawazu, Masahito
    Nakamura, Yoshiaki
    Suzuki, Toshihiro
    Kitano, Shigehisa
    Nakatsura, Tetsuya
    Kuwata, Takeshi
    Shitara, Kohei
    Ikeda, Masafumi
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] Phase II study of gemcitabine and cisplatin in locally advanced or metastatic gallbladder or bile duct adenocarcinoma.
    Servienti, PJ
    Carraro, S
    Bruno, MF
    Odena, MSC
    Felci, N
    Montiel, M
    Roca, E
    Araujo, CE
    ANNALS OF ONCOLOGY, 2000, 11 : 71 - 71
  • [36] A novel trial methodology to test interventions with very large effect sizes: the case of dostarlimab in mismatch repair-deficient, locally advanced rectal cancer
    Kerrington Powell
    Timothée Olivier
    Vinay Prasad
    Trials, 23
  • [37] Clinical responses to PD-1 inhibition and their molecular characterization in six patients with mismatch repair-deficient metastatic cancer of the digestive system
    Daniela Hirsch
    Timo Gaiser
    Kirsten Merx
    Simone Weingaertner
    Michael Forster
    Alexander Hendricks
    Matthias Woenckhaus
    Thomas Schubert
    Ralf-Dieter Hofheinz
    Deniz Gencer
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 263 - 273
  • [38] A novel trial methodology to test interventions with very large effect sizes: the case of dostarlimab in mismatch repair-deficient, locally advanced rectal cancer
    Powell, Kerrington
    Olivier, Timothee
    Prasad, Vinay
    TRIALS, 2022, 23 (01)
  • [39] Clinical responses to PD-1 inhibition and their molecular characterization in six patients with mismatch repair-deficient metastatic cancer of the digestive system
    Hirsch, Daniela
    Gaiser, Timo
    Merx, Kirsten
    Weingaertner, Simone
    Forster, Michael
    Hendricks, Alexander
    Woenckhaus, Matthias
    Schubert, Thomas
    Hofheinz, Ralf-Dieter
    Gencer, Deniz
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (01) : 263 - 273
  • [40] Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?
    Christenson, Eric S.
    Meyer, Jeffrey
    CURRENT ONCOLOGY REPORTS, 2022, 24 (11) : 1373 - 1375
12345